NORDISK BIOGASS AS

Nordisk Biogass

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: KH
Kristian Haug1974
Chairman of the board: BR
Bjørn Rygg1963
Years since formation: 21 years; since Jan 31, 2003
Type: Limited company
VAT registered: Yes
Number of employees: 7

Ownership

Number of shares and share classes: 274,582; 1 share class
Total number of shareholders: 3; 2 companies, 1 person
Belongs to group of

Financials

Total operating income 2023: 23,393,062; NOK
Annual total result 2023: -15,429,556; NOK
Total equity 2023: -18,683,625; NOK

Last update: Dec 9, 2024

Management

Management / administration

Name	Role	Shares
KH Kristian Haug 1974	Managing Director/CEO	-

Board

Name	Role	Shares
BR Bjørn Rygg 1963	Chairman	25 % indirectly
OØ Olav Østhus 1989	Board Member	-
TS Torgeir Straand 1981	Board Member	38.58 % indirectly

Others

Name	Role	Shares
H HAUGERUD REGNSKAPSKONTOR AS	Accountant	-
P PRICEWATERHOUSECOOPERS AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
TS Torgeir Straand 1981	Board Member	38.58 % indirectly
IH Ingvar Hellestad 1967	-	28.17 % indirectly
BR Bjørn Rygg 1963	Chairman	25 % indirectly
HK Halvard Kaasa 1948	-	2.12 % indirectly
EL Eivind Lønheim 1947	-	1.93 % indirectly

Last update: Oct 2, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
T TELEMARK TECHNOLOGIES HOLDING AS	Ordinary shares	204,087	74.33 %
B BRI AGRI AS	Ordinary shares	68,645	25 %
JH Jon Hovland 1949	Ordinary shares	1,850	0.67 %

Last update: May 24, 2024

Group structure

TELEMARK ENERGY AS
Total operating income 2023: NOK 0
Operating profit 2023: NOK -73,165
Employees: 0

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	23,393,062	5,617,318	1,605,000
Annual Total Result	-15,429,556	-3,528,931	-16,909
Total assets	13,897,120	10,578,626	2,506,562
Total liabilities	32,580,745	13,832,695	2,231,699
Total equity	-18,683,625	-3,254,069	274,863

P&L

Year	2023	2022	2021
Total operating income	23,393,062	5,617,318	1,605,000
Total operating costs	38,357,186	9,125,039	1,612,230
Operating result	-14,964,124	-3,507,721	-7,230
Financial income/costs	-465,432	-21,210	-9,679
Profit before tax	-15,429,556	-3,528,931	-16,909
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-15,429,556	-3,528,931	-16,909

Balance overview

Year	2023	2022	2021
Total fixed assets	2,178,462	2,698,422	0
Total current assets	11,718,658	7,880,204	2,506,562
Total assets	13,897,120	10,578,626	2,506,562
Short term debt	25,741,473	11,731,639	196,432
Long term debt	6,839,272	2,101,056	2,035,267
Total liabilities	32,580,745	13,832,695	2,231,699
Contributed capital	510,615	510,615	510,615
Retained earnings	-19,194,240	-3,764,684	-235,752
Total equity	-18,683,625	-3,254,069	274,863
Total equity and liabilities	13,897,120	10,578,626	2,506,562

NORDISK BIOGASS AS985 309 434